Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment
Author:
Affiliation:
1. Pharsight; a Certara Company; Montreal QC Canada
2. Pharsight; a Certara Company; Sunnyvale CA USA
3. Asahi Kasei Pharma America Corporation; Waltham MA USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Reference12 articles.
1. A domain composed of epidermal growth factor like structures of human thrombomodulin is essential for thrombin binding and for protein C activation;Suzuki;J Biol Chem.,1989
2. Do-all receptor takes on coagulation, inflammation;Esmon;Nat Med.,2005
3. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial;Saito;J Thromb Hemost.,2007
4. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial;Aikawa;Shock.,2011
5. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism;Abeyama;J Clin Invest.,2005
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recombinant soluble thrombomodulin attenuates cisplatin-induced intestinal injury by inhibiting intestinal epithelial cell-derived cytokine secretion;Molecular Biology Reports;2023-08-26
2. Bleeding events associated with recombinant human soluble thrombomodulin, classified according to renal function, in sepsis-induced disseminated intravascular coagulation;Int. Journal of Clinical Pharmacology and Therapeutics;2023-07-01
3. OPTIMAL PLASMA CONCENTRATION OF THROMBOMODULIN ALFA TO TREAT SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION;Shock;2023-06-22
4. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis;Thrombosis Research;2023-06
5. Promotion of Appropriate Use of Recombinant Thrombomodulin and Improvement of Infectious DIC Withdrawal Rate by Intervention of the Ward Pharmacist;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3